Post-IPO Equity Medical Companies

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Aeroclean Technologies develops an interior space air purification technology company.

Trajan is a biotech company that develops and commercializes technologies that enable analytical systems.

Delta 9 Cannabis is a company with a large, expanding production facility licensed to produce and sell medical marijuana.

Redx Pharma is a drug discovery and development company.

WELL Health Technologies is the owner and operator of a portfolio of Primary Healthcare facilities.

AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.

The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Kanabo is creating a new standard in the medical cannabis industry by building an ecosystem.

Braxia Scientific specializes in medicinal mushroom and mushroom-infused products.

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Clover is a healthcare technology company helping members live their healthiest lives with its Medicare Advantage plans.

DocGo is a telehealth company offering mobile medical services, on-site event medical services, and transportation.

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Clever Leaves is a multi-national operator (MNO) and a licensed producer of pharmaceutical-grade medical cannabis.